Mostrar el registro sencillo del ítem

dc.contributor.authorCianciosi, Danila
dc.contributor.authorArmas Diaz, Yasmany
dc.contributor.authorGrosso, Giuseppe
dc.contributor.authorQuiles Morales, José Luis 
dc.contributor.authorGiampieri, Francesca
dc.contributor.authorBattino, Maurizio
dc.date.accessioned2024-04-10T10:02:56Z
dc.date.available2024-04-10T10:02:56Z
dc.date.issued2024
dc.identifier.citationCurrent Opinion in Food Science 2024, 55:101109 [10.1016/j.cofs.2023.101109]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/90593
dc.description.abstractMetabolic syndrome (MetS), obesity, and diabetes mellitus (DM) are the most common metabolic disorders (MDs) in the world, characterized by abnormalities in body’s metabolic processes. The typical diagnosis of MDs is usually executed by monitoring the levels of specific biochemical markers, but diagnostic imaging may provide valuable complementary information in MDs, offering advantages in diagnosis, target organ monitoring, follow-up, and development of new therapeutic approaches. The aim of this review is to summarize and discuss the studies published in the literature about the connection between images deriving from the diagnostic techniques and the key biochemical markers in the main MDs, in order to gain a comprehensive view of the different disorders.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleAssociation between diagnostic imaging and biochemical markers: a possible tool for monitoring metabolic disorderses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/j.cofs.2023.101109
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional